Cabaletta Bio Stock Alpha and Beta Analysis
| CABA Stock | USD 1.87 0.39 17.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cabaletta Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cabaletta Bio over a specified time horizon. Remember, high Cabaletta Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cabaletta Bio's market risk premium analysis include:
Beta 1.1 | Alpha (1.67) | Risk 6.28 | Sharpe Ratio (0.25) | Expected Return (1.60) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cabaletta |
Cabaletta Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cabaletta Bio market risk premium is the additional return an investor will receive from holding Cabaletta Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cabaletta Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cabaletta Bio's performance over market.| α | -1.67 | β | 1.10 |
Cabaletta Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cabaletta Bio's Buy-and-hold return. Our buy-and-hold chart shows how Cabaletta Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cabaletta Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabaletta Bio shares will generate the highest return on investment. By understating and applying Cabaletta Bio stock market price indicators, traders can identify Cabaletta Bio position entry and exit signals to maximize returns.
Cabaletta Bio Return and Market Media
The median price of Cabaletta Bio for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 4.29 with a coefficient of variation of 18.55. The daily time series for the period is distributed with a sample standard deviation of 0.8, arithmetic mean of 4.34, and mean deviation of 0.54. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Bollard Catherine of 22000 shares of Cabaletta Bio subject to Rule 16b-3 | 08/30/2024 |
2 | Disposition of 258456 shares by 5am Ventures V, L.p. of Cabaletta Bio at 13.0 subject to Rule 16b-3 | 09/06/2024 |
3 | Disposition of 11000 shares by Gwendolyn Binder of Cabaletta Bio at 1.01 subject to Rule 16b-3 | 09/13/2024 |
4 | Lynx1 Capital Management LP Lowers Stock Position in Cabaletta Bio, Inc. - MarketBeat | 09/27/2024 |
5 | Acquisition by Nichtberger Steven of 333500 shares of Cabaletta Bio at 11.47 subject to Rule 16b-3 | 10/04/2024 |
6 | State Street Corps Strategic Reduction in Cabaletta Bio Inc Holdings | 10/17/2024 |
7 | Were Not Very Worried About Cabaletta Bios Cash Burn Rate - Yahoo Finance | 10/30/2024 |
8 | Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update | 11/14/2024 |
9 | Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024 | 11/18/2024 |
10 | Acquisition by Simon Mark of 7000 shares of Cabaletta Bio at 0.9764 subject to Rule 16b-3 | 11/20/2024 |
11 | Cabaletta Bios SWOT analysis CAR-T pioneers stock faces pivotal moment - Investing.com | 11/21/2024 |
About Cabaletta Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cabaletta or other stocks. Alpha measures the amount that position in Cabaletta Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Cabaletta Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Cabaletta Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cabaletta Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cabaletta Bio. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cabaletta Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cabaletta Bio Backtesting, Cabaletta Bio Valuation, Cabaletta Bio Correlation, Cabaletta Bio Hype Analysis, Cabaletta Bio Volatility, Cabaletta Bio History and analyze Cabaletta Bio Performance. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Cabaletta Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.